Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
10.77
+0.14 (1.32%)
At close: Aug 17, 2026, 4:00 PM EDT
10.69
-0.08 (-0.74%)
Pre-market: Aug 18, 2026, 7:36 AM EDT
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $942.35 million as of August 18, 2026. Its market cap has increased by 149.18% in one year.
Market Cap
942.35M
Enterprise Value
484.94M
1-Year Change
149.18%
Ranking
Category
Stock Price
$10.77
ChartMarket Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has decreased from $1.79B to $942.35M, a decrease of -47.49%. That is a compound annual growth rate of -10.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 942.35M | -52.08% |
| Dec 31, 2025 | 1.97B | 357.26% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wave Life Sciences | 1.00B |
| Climb Bio | 1.00B |
| Odyssey Therapeutics | 999.58M |
| Janux Therapeutics | 994.08M |
| Geron | 982.98M |
| Attovia Therapeutics | 977.19M |
| Solid Biosciences | 975.75M |
| Annexon | 972.54M |